Active Pharmaceutical Ingredients (APIs) are designed to have a biological effect. In pharmaceutical manufacturing, employees may handle these substances more frequently or at different concentrations than patients.
An Occupational Exposure Limit (OEL) provides a clear, evidence-based level for managing airborne exposure and protecting worker health. However, not every API has an established OEL, making it difficult to know what level of exposure should be controlled.
IOM reviews the available toxicological and pharmaceutical evidence to develop a scientifically robust OEL, helping you make informed decisions about exposure controls and protect your people.